Disposition of 1634 shares by Mark Dmytruk of Ginkgo Bioworks subject to Rule 16b-3
| DNA Stock | USD 8.26 0.31 3.90% |
About 55% of Ginkgo Bioworks' investors are presently thinking to get in. The analysis of overall sentiment of trading Ginkgo Bioworks Holdings stock suggests that some investors are interested at this time. The current market sentiment, together with Ginkgo Bioworks' historical and current headlines, can help investors time the market. In addition, many technical investors use Ginkgo Bioworks Holdings stock news signals to limit their universe of possible portfolio assets.
Ginkgo |
Filed transaction by Ginkgo Bioworks Holdings Officer: See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at telegraph.co.uk
 |
Ginkgo Bioworks Fundamental Analysis
We analyze Ginkgo Bioworks' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ginkgo Bioworks using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ginkgo Bioworks based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Ginkgo Bioworks is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Ginkgo Bioworks Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ginkgo Bioworks stock to make a market-neutral strategy. Peer analysis of Ginkgo Bioworks could also be used in its relative valuation, which is a method of valuing Ginkgo Bioworks by comparing valuation metrics with similar companies.
Peers
Ginkgo Bioworks Related Equities
| ENVB | Enveric Biosciences | 3.13 | ||||
| ELEV | Elevation Oncology | 1.59 | ||||
| OCEA | Ocean Biomedical | 2.74 | ||||
| HEPA | Hepion Pharmaceuticals | 4.48 |
Complementary Tools for Ginkgo Stock analysis
When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |